IUGT (in utero gene transfer)
Used to correct genetic defects of somatic cells by transfer of gene(s) into the unborn fetus. Its advantage is that it can be applied early during embryonic development before irreversible damage occurs, e.g., in various neurological diseases (Tay-Sachs, Niemann-Pick, Lesh-Nyhan, Sandhoff, Leigh, leukodystrophies, gangliosidoses, immunological disorders, thalassemias, osteopetrosis). It is less likely that IUGT involves vector or cell rejection. The treatment of hematopoietic stem cells may be more successful. Animal experiments have yielded encouraging results. Its drawbacks are the potential risk to the mother and the fetus. Also, the vector DNA may cause undesirable insertions or mutations in the germline. ART, gene therapy, Heikkila A et al 2001 Gene Ther 8:784.
Reference Work Entry Metrics
- IUGT (in utero gene transfer)
- Reference Work Title
- Encyclopedia of Genetics, Genomics, Proteomics and Informatics
- p 1042
- Print ISBN
- Online ISBN
- Springer Netherlands
- Copyright Holder
- Springer Science+Business Media
- Additional Links
- Industry Sectors
To view the rest of this content please follow the download PDF link above.